| Date |
Research Question / Title |
Unique ID |
Research Team |
|
October 13, 2021
|
What is the epidemiology of variants and what are the implications for healthcare? [Evergreen]
|
EOC031801v014 RR Table
|
EOC
|
|
October 13, 2021
|
What is the epidemiology of variants and what are the implications for healthcare?
|
EOC031801v014 RR
|
EOC
|
|
October 7, 2021
|
What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general
population?
|
EOC210902 RR Table
|
EOC
|
|
October 7, 2021
|
What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population?
|
EOC210902 RR
|
EOC
|
|
September 30, 2021
|
What is the evidence for the effectiveness of universal mask use in the pediatric population?
|
EOC210901 RR Table
|
EOC
|
|
September 30, 2021
|
What is the evidence for the effectiveness of universal mask use in the pediatric population?
|
EOC210901 RR
|
EOC
|
|
August 24, 2021
|
What are other jurisdictions offering for incentive-based COVID-19
vaccine campaigns?
|
EOC210501v2 RR
|
EOC
|
|
August 24, 2021
|
What are other jurisdictions offering for incentive-based COVID-19
vaccine campaigns?
|
EOC210501v2 RR Table
|
EOC
|
|
August 17, 2021
|
What are the causes of vaccine hesitancy? What programs/approaches have been successful in reducing vaccine hesitancy?
|
EOC012201v3 RR
|
EOC
|
|
August 17, 2021
|
What are the causes of vaccine hesitancy? What programs/approaches have been successful in reducing vaccine hesitancy? [Update]
|
EOC012201v3 RR Table
|
EOC
|
|
June 21, 2021
|
What are the ethical/legal aspects of vaccine requirements?
|
EOC210503 RR
|
EOC
|
|
June 21, 2021
|
What are the ethical/legal aspects of vaccine requirements?
|
EOC210503 RR Table
|
EOC
|
|
June 10, 2021
|
What are legitimate exemptions/contraindications for COVID-19 vaccines from a medical point of view?
|
EOC210502 RR
|
EOC
|
|
June 10, 2021
|
What are legitimate exemptions/contraindications for COVID-19 vaccines from a medical point of view?
|
EOC210502 RR Table
|
EOC
|
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR
|
EOC
|
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR Table
|
EOC
|
|
March 18, 2021
|
What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)?
|
EOC031001 RR
|
EOC
|
|
March 15, 2021
|
Long COVID: What does it mean for the healthcare system and programs to deal with it?
|
EOC021901 RR
|
EOC
|
|
February 12, 2021
|
How effective is surveillance antigenic testing?
|
EOC012601 RR
|
EOC
|
|
February 4, 2021
|
Are there validated clinical prediction tools of which Covid-19 inpatients are most probable to require ICU level care?
|
EOC012001 RR
|
EOC
|
